MktsMarkets

Organogenesis Holdings Inc.
NASDAQ: ORGOKey statistics
ORGO News
Stories mentioning ORGO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 37,228 | 225,607 | 150,864 | 101,005 | 86,693 | 126,656 | 115,177 | 130,234 |
| Cost of Goods Sold | 23,723 | 31,051 | 26,796 | 29,198 | ||||
| Gross Profit | 62,970 | 95,605 | 88,381 | 101,036 | ||||
| Operating Expenses | ||||||||
| Research & Development | 15,161 | 10,286 | 13,221 | 10,395 | 10,640 | 11,530 | 10,344 | 15,587 |
| Sales General & Admin | 65,186 | 100,174 | 79,743 | 73,810 | 72,509 | 73,856 | 71,795 | 76,540 |
| Total Operating Expenses | 106,119 | 162,318 | 130,137 | 113,581 | 113,439 | 145,133 | 108,935 | 144,126 |
| Operating Income (Loss) | (68,891) | 63,289 | 20,727 | (12,576) | (26,746) | 10,219 | 6,242 | (13,892) |
| Interest Income | ||||||||
| Interest Expense | 620.00 | |||||||
| Other Expense | 38.00 | (98.00) | 18.00 | 73.00 | 2.00 | (27.00) | 52.00 | (28.00) |
| Pretax Income | (68,473) | 63,427 | 21,160 | (11,834) | (25,783) | 10,253 | 5,823 | (14,540) |
| Tax Provision | (15,317) | 19,727 | (407.00) | (2,442) | (6,940) | 2,580 | (6,508) | 2,503 |
| Net Income (Loss) | (53,156) | 43,700 | 21,567 | (9,392) | (18,843) | 7,673 | 12,331 | (17,043) |
| Earnings Per Share (Basic) | (0.44) | 0.34 | 0.11 | (0.10) | (0.17) | 0.06 | 0.09 | (0.13) |
| Earnings Per Share (Diluted) | (0.44) | 0.34 | 0.11 | (0.10) | (0.17) | 0.06 | 0.09 | (0.13) |
| Weighted Average Shares Outstanding (Basic) | 127,797 | 126,738 | 126,882 | 126,854 | 126,296 | 131,673 | 132,575 | 132,573 |
| Weighted Average Shares Outstanding (Diluted) | 127,797 | 130,248 | 130,849 | 133,927 | 126,296 | 131,673 | 133,927 | 132,573 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ORGO
Organogenesis Holdings Inc. (NASDAQ: ORGO) is a stock listed on the Nasdaq Stock Market under the ticker symbol ORGO. It last traded at $0.8100 (Nov 6, 2026, 4:00 PM ET), down 3.2% on the day. That gives Organogenesis a market capitalisation of $104.6M.
Over the past 52 weeks ORGO has traded between $0.7300 and $7.08.
Revenue for the quarter ended Mar 31, 2026 was $37.2M; a net loss of $53.2M. Revenue was down 57.1% from $86.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $37.2M | -$53.2M | -142.8% |
| Dec 31, 2025 | $225.6M | $43.7M | 19.4% |
| Sep 30, 2025 | $150.9M | $21.6M | 14.3% |
| Jun 30, 2025 | $101.0M | -$9.4M | -9.3% |
From Organogenesis’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…